High prevalence of colonic polyps in white males with esophageal adenocarcinoma

Diseases of the Colon and Rectum

Volumn 52, Issue 2, 2009, Pages 299-304

  Bollschweiler, Elfriede ^a   Schloesser, Thomas ^a   Leers, Jessica ^a   Vallböhmer, Daniel ^a   Schäfer, Hartmut ^a   Hölscher, Arnulf H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adenocarcinoma; Barrett's esophagus; Colonic polyps; Epidemiology; Esophagus; Squamous cell carcinoma

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; CASE CONTROL STUDY; CAUCASIAN; CLINICAL EVALUATION; COLON POLYP; COLONOSCOPY; CONTROLLED STUDY; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREOPERATIVE CARE; PREVALENCE; ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGUS TUMOR; MIDDLE AGED; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; COLONIC POLYPS; COLONOSCOPY; ESOPHAGEAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 64049108153     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e318197d06f     Document Type: Article

References (39)

1. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:549Y55.
2. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645Y54.
3. Drovdlic C, Goddard K, Chak A, et al. Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinoma. J Med Genet 2003;40:651Y6.
4. Bray F, Sankila R, Ferlay J, Parkin D. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002; 38:99Y166.
5. Vogelstein B, Fearon E, Hamilton S, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319: 525Y32.
6. Huttenbach Y, Hamilton C, Lechago J, Younes M. Nondysplastic and dysplastic Barrett's mucosa and adenocarcinoma lack a subepithelial myofibroblastic cell layer. Anticancer Res 2003;23:2261Y5.
7. Flejou J. Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut 2005;54(Suppl 1):i6Y12.
8. Sontag SJ, Schnell TG, Chejfec G, et al. Barrett's oesophagus and colonic tumours. Lancet 1985;1:946Y9.
9. Howden C, Hornung C. A systematic review of the association between Barrett's esophagus and colon neoplasms. Am J Gastroenterol 1995;90:1814Y9.
10. Cauvin JM, Goldfain D, Lerhun M, et al. Multicenter prospective controlled study of Barrett's esophagus and colorectal adenomas. Lancet 1995;346:1391Y4.
11. Poorman JC, Lieberman DA, Ippoliti AF, Weber LJ, Weinstein WM. The prevalence of colonic neoplasia in patients with Barrett's esophagus: prospective assessment in patients 50Y80 years old. Am J Gastroenterol 1997;92:592Y6.
12. Siersema P, Yu S, Sahbaie P, Steyerberg E, Simpson P, Kuipers E, Triadafilopoulos G. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc 2006;63: 581Y6.
13. Samanic C, Chow W, Gridley G, Jarvholm B, Fraumeni J. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006;17:901Y9.
14. Kagei K, Hosokawa M, Shirato H, Kusumi T, Shimizu Y, Watanabe A, Ueda M. Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer. Jpn J Clin Oncol 2002;32:120Y7.
15. Motoyama S, Saito R, Kitamura M, Ogawa J. Outcomes of active operation during intensive followup for second primary malignancy after esophagectomy for thoracic squamous cell esophageal carcinoma. J Am Coll Surg 2003;197:914Y20.
16. Altomare J, Komar M. A tubular adenoma arising in a colonic interposition. J Clin Gastroenterol 2006;40:765Y6.
17. Liau C, Hsueh S, Yeow K. Primary adenocarcinoma arising in esophageal colon interposition: report of a case. Hepatogastroenterology 2004;51:748Y9.
18. Vaughan T, Kiemeney L, McKnight B. Colorectal cancer in patients with esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 1995;4:93Y7.
19. Bollschweiler E, Wolfgarten E, Nowroth T, Rosendahl U, Monig S, Holscher A. Vitamin intake and risk of subtypes of esophageal cancer in Germany. J Cancer Res Clin Oncol 2002; 128:575Y80.
20. Chen H, Ward M, Graubard B, et al. Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr 2002;75:137Y44.
21. Calle E, Thun M. Obesity and cancer. Oncogene 2004;23: 6365Y78.
22. Lindblad M, Rodriguez L, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric noncardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 2005;16:285Y94.
23. Cowey S, Quast M, Belalcazar L, Wei J, Deng X, Given R, Singh P. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer 2005;103:2643Y53.
24. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109SY20S.
25. MacInnis R, English D, Hopper J, Haydon A, Gertig D, Giles G. Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev 2004;13:553Y9.
26. Moore T, Jepeal L, Boylan M, et al. Gastrin stimulates receptor-mediated proliferation of human esophageal adenocarcinoma cells. Regul Pept 2004;120:195Y203.
27. Robertson D, Ayres R, Smith C. Screening for colonic cancer in patients with Barrett's oesophagus. BMJ 1989;298:650.
28. Post A, Achkar E, Carey W. Prevalence of colonic neoplasia in patients with Barrett's esophagus. Am J Gastroenterol 1993; 88:877Y80.
29. Lagergren J, Nyren O. No association between colon cancer and adenocarcinoma of the oesophagus in a population based cohort study in Sweden. Gut 1999;44:819Y21.
30. Solaymani-Dodaran M, Logan R, West J, Card T, Coupland C. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Scand J Gastroenterol 2004;39:680Y5.
31. Laitakari R, Laippala P, Isolauri J. Barrett's esophagus is not a risk factor for colonic neoplasia: a case-control study. Ann Med 1995;27:499Y502.
32. Cauvin J, Goldfain D, Le Rhun, et al. Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett. Lancet. 1995;346:1391Y4.
33. Huppe D, Lemberg L, Felten G. Effectiveness and patient tolerance of screening colonoscopy: first results. Z Gastroenterol 2004;42:591Y8.
34. Schuz J, Schon D, Batzler W, et al. Cancer registration in Germany: current status, perspectives and trends in cancer incidence 1973Y1993. J Epidemiol Biostat 2000;5:99Y107.
35. Loeve F, van Ballegooijen M, Snel P, Habbema J. Colorectal cancer risk after colonoscopic polypectomy: a populationbased study and literature search. Eur J Cancer 2005;41: 416Y22.
36. Loeve F, Boer R, Zauber A, et al. National Polyp Study data: evidence for regression of adenomas. Int J Cancer 2004;111: 633Y9.
37. Liljegren A, Lindblom A, Rotstein S, Nilsson B, Rubio C, Jaramillo E. Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut 2003;52:1140Y7.
38. Huang E, Whelan R, Gleason N, et al. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps. Surg Endosc 2001;15: 646Y8.
39. Hyman N, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 2004;47: 2101Y4.